Close MenuClose
Close Menu

Adam D. Highley, MD

Assistant Professor

Adam Highley

Contact

School of Medicine
Department of Medicine
Pulmonary, Critical Care, and Sleep Medicine
Critical Care Medicine Fellowship
Pulmonary and Critical Care Fellowship

Adam D. Highley, MD

Assistant Professor

Board certified in Internal Medicine and Pulmonary Disease

Areas of Interest: Critical care/cardiac arrest simulation training, COPD/asthma, lung cancer diagnosis
Pulmonary and Critical Care Medicine Fellowship: Creighton University School of Medicine, Omaha, NE
Residency: SSM Saint Mary’s Health Center, St. Louis, MO
Medical School: American University of Antigua College of Medicine

Department

Medicine

Position

Assistant Professor

Articles

  • Chest
    Anani, A, Walters, R, Jackson, I, Loranger, A, Alali, Y, Highley, A. COPD and Psychiatric Illness - A STUDY OF EPEDMIOLOGY AND EFFECTS ON MORTALITY - CHEST 2021
    4, p. A1904 2021
  • Chest
    Alghoula, F & Gbadamusi, M & Highley, Adam. : Anemia as a prognostic factor in patients with severe sepsis and septic shock, . . . retrospective study using NIS database_ CHEST
    156, p. A1041 2019
  • Journal of Thoracic Disease
    Waste not, want not: diagnostic material found in suction syringe aspirate during endobronchial ultrasound guided transbronchial needle aspiration.Jagan N1, Landeen CA1, Moore DR1, Highley AD1, Walters RW2, DePew ZS1.PMID 31559029 
    11;8, p. 3270-3275 2019
  • US Pharmacist
    Highley AD, Cookman C, Morrow LE, Malesker MA.  Severe Asthma: An Update for 2019.  U.S. Pharmacist.  2019;44(7):HS2-HS7. 
    2019 44;7, p. HS2-HS7 2019

Presentations

  • Asthma Updates, Everything You Need to Know about COPD, Lung Cancer Screening, Controversies of Respiratory Infections, Deep Vein Thrombosis and Pulmonary Embolism, Challenging Pulmonary Cases 2022
  • Creighton University Pulmonary Critical Care Annual CME Conference - Updates in Pulmonary Critical Care Literature – 10/2021 2021
  • Feedback in 2021 - Creighton University Pulmonary, Critical Care Grand Rounds – 9/2021 2021
  • CHI-Fundamentals of Critical Care Support 2021
  • CHI-Pulmonary Function Testing for the Primary Care Physician – 3/10/2021 2021
  • Imposter Syndrome - Creighton University Pulmonary, Critical Care Grand Rounds – 10/12/2020 2020
  • Medical Management of the Patient with COVID-19 - Creighton University COVID-19 Course – 5/2020 2020
  • Acute Respiratory Distress Syndrome o MCC Respiratory Therapy Program Lecture – 10/16/2019 2019
  • Emotional Intelligence in Medicine o Creighton University Pulmonary, Critical Care Grand Rounds – 9/9/2019 2019
  • Randhawa, S., Griffin, E., Dhingra, M., Hiatt, M., Alberts, J., Noble, V., Highley, A. Portopulmonary Hypertension: A Case Report With Management Considerations. American Thoracic Society International Conference, Dallas, TX. 2019
  • Extracorporeal Membrane Oxygenation ECMO o NSRC State Conference – 5/2/2019 2019
  • Extracorporeal Membrane Oxygenation ECMO o CHI Cardiovascular Conference – 5/2/2019 2019
  • In Case You Missed It! – 2018-2019 Updates in Pulmonary and Critical Care Medicine o Creighton University Pulmonary CME Conference – 4/11/2019 2019
  • Sleep Apnea Creighton University Family Medicine CME Conference – 4/6/2019 2019
  • Spirometry Interpretation- Creighton University Family Medicine CME Conference – 4/6/2019 2019
  • Parekh J, Macaraeg J, Klug M, Loranger A, Highley A. A Rare Case of Rhinovirus Associated Acute Respiratory Distress Syndrome in a 51-Year-Old Womano   SCCM Conference – San Diego, CA – February 2019  2019
  • The Feedback Model – Applying Effective Feedback in Educationo   Creighton University Pulmonary, Critical Care Grand Rounds – 8/2/2018  2018
  • Creighton University Pulmonary Critical Care Annual CME Conference - In Case You Missed It! – 2019-2020 Updates in Pulmonary and Critical Care 0020

Industry/Corporation

  • Sub Investigator - GSK COPD CTT116855: A phase III, 52 week, randomized, double-blind, 3-arm parallel group study, comparing the efficacy, safety and tolerability of the fixed dose triple combination FF/UMEC/VI with the fixed dose dual combinations of FF/VI and UMEC/VI, al administered once-daily in the morning via a dry powder inhaler in subjects with chronic obstructive pulmonary disease

  • Sub Investigator - Insmed MAC: A Randomized, Open-Label, Multicenter Study of Liposomal Amikacin for Inhalation (LAI) in Adult Patients with Nontuberculous Mycobacterial (NTM) Lung Infections caused by Mycobacterium avium complex (MAC) that are refractory to treatment

  • Sub Investigator - Janssen: Medically Ill Patient Assessment of Rivaroxaban Versus Placebo IN Reducing Post-Discharge Venous Thrombo-Embolism Risk (MARINER)

  • Sub Investigator: CXA-NP-11-04: A Prospecteive, Randomized, Double Blind, Multicenter, Phase III Study to Assess the Safety and Efficacy of Intravenous Ceftolozane/Tazobactam Compared with Meropenem in Adult Patients with Ventilated Nosocomial Pneumonia.

  • Sub Investigator AstraZeneca: Double-Blind, Randomized, Placebo-controlled, Parallel-group, Phase IV Study to Evaluate the Effect of Aclidinuim Bromide on Long-Term Cardiovascular Safety and COPD Exacerbations in Patients with Moderate to Very Severe COPD (ASCENT COPD)

  • Sub Investigator - AstraZeneca: A Randomized, Double-blind, double dummy, chronic dosing (56 week) Placebo-controlled, Parallel Group, Multicentre, Phase III Study to evaluate the efficacy and safety of 3 doses of Benralizumab in patients with moderate to very severe chronic
    obstructive pulmonary disease with a history of COPD exacerbations

Awards

  • Internal Medicine Teaching Award
    Internal Medicine Teaching Award (Divisional) - 2020
    Division
  • Internal Medicine Teaching Award
    Internal Medicine Teaching Award (Divisional) – 2019
    Division